Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Cancer|June 26, 2013
Extracapsular spread in head and neck carcinoma: impact of site and human papillomavirus statusJessica H Maxwell, Robert L Ferris, William Gooding, et al.
The American Journal of Surgical Pathology|June 15, 2017
Phosphaturic Mesenchymal Tumors: Clinicopathologic, Immunohistochemical and Molecular Analysis of 22 Cases Expanding their Morphologic and Immunophenotypic SpectrumAbbas Agaimy, Michael Michal, Simion Chiosea, et al.
The American Journal of Surgical Pathology|November 15, 2017
Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade CasesSoufiane El Hallani, Aaron M Udager, Diana Bell, et al.
Histopathology|March 8, 2019
Genomic analysis of recurrences and high-grade forms of polymorphous adenocarcinomaAna P M Sebastiao, Fresia Pareja, Rahul Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2014
Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancerNeil D Gross, Julie E Bauman, William E Gooding, et al.
JCI Insight|March 30, 2017
Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancerJulie E Bauman, Umamaheswar Duvvuri, William E Gooding, et al.
Cancer Discovery|June 22, 2012
First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapyMalabika Sen, Sufi M Thomas, Seungwon Kim, et al.
The Journal of Clinical Endocrinology and Metabolism|April 18, 2023
Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized ManagementSimion Chiosea, Steven P Hodak, Linwah Yip, et al.
JAMA Oncology|July 17, 2015
Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell CarcinomaEliezer M Van Allen, Vivian W Y Lui, Ann Marie Egloff, et al.
Cancer Discovery|April 27, 2013
Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkersVivian W Y Lui, Matthew L Hedberg, Hua Li, et al.
Pageof 4